Frenuloplasty for Speech and Myofunctional Outcomes

Sponsor
The Oregon Clinic (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06089629
Collaborator
(none)
50
2
16

Study Details

Study Description

Brief Summary

Children with ankyloglossia (tongue tie) can have abnormal tongue function, putting them at a disadvantage when it comes to speech and articulation. Furthermore, abnormal tongue posture within the oral cavity increases the likelihood of myofunctional disorders.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Lingual frenuloplasty
N/A

Detailed Description

The current body of literature surrounding ankyloglossia and speed delay is mixed. The literature base is riddled with retrospective reviews, poor descriptions of surgical intervention, and the lack of standardized grading schemes with respect to articulation. Furthermore, the candidacy for intervention in these instances only involves children with anterior tongue tie. There is a complete lack of investigation surrounding the impact of posterior tongue tie on articulation.

The other area that has inadequately been studied is the impact ankyloglossia has on myofunctional outcomes. There are data now that demonstrate how ankyloglossia is correlated with a vaulted palate and has long term orthodontic consequences. This study aims to demonstrate how release of posterior tongue tie improves lingual strength and posture.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Frenuloplasty for Speech and Myofunctional Outcomes: a Randomized, Controlled Study
Anticipated Study Start Date :
Dec 1, 2023
Anticipated Primary Completion Date :
Dec 1, 2024
Anticipated Study Completion Date :
Apr 1, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control group

Nonsurgical intervention with speech and myofunctional therapy

Experimental: Intervention group

Surgical intervention with frenuloplasty followed by speech and myofunctional therapy

Procedure: Lingual frenuloplasty
Surgical release of ankyloglossia with suture reorientation of the wound to improve lingual mobility, done under local or general anesthesia

Outcome Measures

Primary Outcome Measures

  1. Speech/Articulation [Baseline (timepoint 0) and 2 months post-intervention (surgical group) or 2 months post-therapy alone (control group)]

    Using the GFTA-3 test of articulation

  2. Tongue mobility [Baseline (timepoint 0) and 2 months post-intervention (surgical group) or 2 months post-therapy alone (control group)]

    Using the TRMR grading scale

  3. Tongue strength [Baseline (timepoint 0) and 2 months post-intervention (surgical group) or 2 months post-therapy alone (control group)]

    Using the IOPI instrument

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Children ages 5-12 with posterior tongue tie who are undergoing treatment just for ankyloglossia

  • Children must already be working with an SLP who has done a speech and myofunctional evaluation

Exclusion Criteria:
  • Children undergoing other procedures at the same time as the frenuloplasty (tonsillectomy, adenoidectomy, etc)

  • Significant medical comorbidities (cardiovascular, neurological, etc)

  • Anterior tongue tie or lip tie

  • Previous lingual surgery

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • The Oregon Clinic

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bobak Ghaheri, MD, Otolaryngologist, The Oregon Clinic
ClinicalTrials.gov Identifier:
NCT06089629
Other Study ID Numbers:
  • Speech2023
First Posted:
Oct 18, 2023
Last Update Posted:
Oct 18, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bobak Ghaheri, MD, Otolaryngologist, The Oregon Clinic
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 18, 2023